Φορτώνει......
Pragmatic trial on inhaled corticosteroid withdrawal in patients with COPD in general practice
The therapeutic value of inhaled corticosteroids (ICSs) for COPD is limited. In published RCTs, ICS could be withdrawn in COPD patients without increasing exacerbation risk when bronchodilator treatment is optimized. Here we report on the feasibility and risks of ICS withdrawal in Dutch general prac...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | NPJ Prim Care Respir Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Nature Publishing Group UK
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7547069/ https://ncbi.nlm.nih.gov/pubmed/33037200 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41533-020-00198-5 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|